DGM
RPRX icon

Delta Global Management’s Royalty Pharma RPRX Stock Holding History

Delta Global Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-44,314
Closed -$1.71M – 217
2025
Q4 		$1.71M Buy
+44,314
New +$1.69M 0.12% 126

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Delta Global Management's RPRX Position: Q1 2026 in Review

Delta Global Management sold out of Royalty Pharma (RPRX) in Q1 2026, closing a stake of 44,314 shares — an estimated $1.71M sold.

Delta Global Management first reported a position in RPRX in Q4 2025 and held it in 1 quarter. The position peaked at $1.71M in Q4 2025. 592 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Delta Global Management reported no remaining Royalty Pharma position as of Q1 2026 after selling out during the quarter.
  • Delta Global Management sold 44,314 Royalty Pharma shares in Q1 2026, an estimated $1.71M.
  • Delta Global Management first reported a position in Royalty Pharma in Q4 2025 and held it in 1 quarter.
  • Delta Global Management's Royalty Pharma position peaked at $1.71M in Q4 2025.
  • 592 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Delta Global Management's 13F filing for Q1 2026, filed 15 May 2026.